This article is a section of a longer paper on Direct Primary Care (DPC) that was introduced in an earlier piece -- Health Plan Rorschach Test: Direct Primary Care. The following excerpt from that ...

Mason Hayes & Curran takes a look at the key aspects of a decision regarding oral hearings and the Data Protection Commissioner, and the potential legal impact it might have. The recent High Court ...

PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Research Corporation (NASDAQ:ARWR) today announced that David Lewis, Ph.D., Vice President Biology and Site Head of its Madison, WI research and ...

One of the biggest technology challenges organizations face is managing an increasingly complex environment that might include multiple cloud services and providers, on-site data centers, edge systems ...

The right to privacy and data protection would cease to exist if the Irish Data Protection Commission's (DPC) draft decision in a major inquiry into Facebook is allowed to stand, Norwegian authorities ...

The Irish Data Protection Commission (DPC) is clearly under siege. Negative global and Irish press coverage has accrued in recent weeks, alongside criticisms by fellow EU data protection authorities ...

TEL AVIV, Israel, April 9, 2018 /PRNewswire/ -- SharpLight Technologies Ltd. announced today the launch of two advanced product lines – the OmniMax series and the Rapid series. The OmniMax devices ...

SharpLight Technologies Ltd. announced the launch of two advanced product lines – the OmniMax series and the Rapid series. The OmniMax devices offer 'all-in-one' solutions that house multiple ...

PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Research Corporation (NASDAQ:ARWR) today announced that Darren Wakefield, Ph.D., one of its Senior Scientists at its Madison, WI research and development ...

BOSTON, Dec. 4, 2019 /PRNewswire-PRWeb/ -- DPC DATA, Roseland, NJ, announced it has signed a new agreement with Fidelity Investments®, for provision of DPC's municipal information. DPC DATA ...

- Arrowhead Receives License from Alnylam to Develop RNAi Therapeutic Toward Hepatitis B Virus (HBV) - - Alnylam Gains Access to Arrowhead's Dynamic Polyconjugate (DPC) Delivery Technology for ...